Additionally, our study shows that IBTK overexpression suppresses AS-induced SG assembly and that ablation of IBTK sensitizes cancer cells to eIF4A inhibitor-induced cell death, making IBTK a potential therapeutic target to overcome intrinsic resistance to eIF4A inhibitors. This evidence concerns the gene EIF4A2 and cancer.